Terumo Corporation (TRUMY)
OTCMKTS · Delayed Price · Currency is USD
13.61
+0.02 (0.15%)
Feb 11, 2026, 3:35 PM EST
Terumo Revenue
Terumo had revenue of 274.97B JPY in the quarter ending September 30, 2025, with 9.77% growth. This brings the company's revenue in the last twelve months to 1.06T, up 7.68% year-over-year. In the fiscal year ending March 31, 2025, Terumo had annual revenue of 1.04T with 12.40% growth.
Revenue (ttm)
1.06T JPY
Revenue Growth
+7.68%
P/S Ratio
2.81
Revenue / Employee
34.73M JPY
Employees
30,591
Market Cap
20.20B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04T | 114.31B | 12.40% |
| Mar 31, 2024 | 921.86B | 101.65B | 12.39% |
| Mar 31, 2023 | 820.21B | 116.91B | 16.62% |
| Mar 31, 2022 | 703.30B | 89.46B | 14.57% |
| Mar 31, 2021 | 613.84B | -15.06B | -2.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Ozop Energy Solutions | 323.50K |
| Standard Dental Labs | 306.82K |
| Hear AtLast Holdings | 93.20K |
| Cardiac Biotech Solutions | 50.37K |
Terumo News
- 4 weeks ago - Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Terumo Launches SurTract Safety Syringe In US Market - Nasdaq
- 3 months ago - Q2 2026 Terumo Corp Earnings Presentation Transcript - GuruFocus
- 3 months ago - Terumo Corporation (TRUMY) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Terumo reports 1H results - Seeking Alpha
- 3 months ago - OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation - GlobeNewsWire
- 3 months ago - Orchestra BioMed, Terumo Sign $30 Million Strategic Agreements For Virtue SAB - Nasdaq
- 5 months ago - Terumo Acquiring Its Way Into The Intriguing Organ Donation Market - Seeking Alpha